You are here: Industry Insights > AstraZeneca

News List

UK MHRA approves Oxford/AstraZeneca COVID-19 vaccine expresspharma
December 31, 2020
Britain has ordered 100 million doses of the jab, with 40 million expected to be available by the end of March.
AstraZeneca and Oxford-made Covid-19 vaccine not ready for EU market approval pharmaceutical-technology
December 30, 2020
The European Medicines Authority (EMA) has said that the drug maker AstraZeneca and the University of Oxford’s COVID-19 vaccine may not be approved in January next year.
AstraZeneca says its vaccine should be effective against new coronavirus variant expresspharma
December 24, 2020
British drugmaker AstraZeneca told Reuters on Tuesday its COVID-19 vaccine should be effective against the new coronavirus variant, adding that studies were under way to fully probe the impact of the mutation.
AZ, Amgen’s SOURCE trial misses primary endpoint pharmatimes
December 23, 2020
AstraZeneca and Amgen have announced that a phase III trial of their new medicine tezepelumab failed to meet the primary endpoint in patients with severe, oral corticosteroid-dependent asthma.
AstraZeneca’s Asthma drug Benralizumab gets marketing approval from DCGI expresspharma
December 23, 2020
Fasenra is an add-on maintenance treatment for patients with severe eosinophilic asthma.
India likely to approve AstraZeneca vaccine by next week – sources expresspharma
December 23, 2020
AstraZeneca-Oxford shot is considered vital for lower-income countries and those in hot climates.
Green light for AZ’s Tagrisso in early-stage lung cancer pharmatimes
December 22, 2020
The US Food and Drug Administration (FDA) has approved AstraZeneca’s Tagrisso (osimertinib) for the treatment of adult patient with early-stage epidermal growth factor receptor-mutated (EGFRm) non-small cell lung cancer (NSCLC).
AstraZeneca Pharma India gets DCGI nod for benralizumab injection, Fasenra expresspharma
December 22, 2020
It is indicated as an add-on maintenance treatment for severe asthma with an eosinophilic phenotype in adult patients.
Oxford/AstraZeneca vaccine likely to get approval by year-end in UK expresspharma
December 21, 2020
AstraZeneca has said a further 15 million doses of active ingredients are ready and can be filled into vials in a matter of days.
AstraZeneca Initiates Study of Antisense Med Targeting PCSK9 to Lower LDL-Cholesterol americanpharmaceuticalreview
December 17, 2020
Ionis Pharmaceuticals announced that biopharmaceutical company AstraZeneca has initiated a Phase 2b clinical trial of ION449 (AZD8233), an investigational antisense medicine designed to reduce blood cholesterol levels in patients with dyslipidemia by ...

Previous page 1 2 3 4 5 6 7 8 9 10 ... 80 81 Next page